The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial.
Hongyuan GuRui ZhouJing NiXia XuXianzhong ChengYan LiXiaoxiang ChenPublished in: Journal of ovarian research (2020)
SNAC might be another choice for PSOCs were not suitable for directly SCR. Optimal SCR had survival benefit in PSOCs whenever underwent SNAC or not.